The gut microbiota and its interactions with cardiovascular disease

Abstract

Summary The intestine is colonized by a considerable community of microorganisms that cohabits within the host and plays a critical role in maintaining host homeostasis. Recently, accumulating evidence has revealed that the gut microbial ecology plays a pivotal role in the occurrence and development of cardiovascular disease (CVD). Moreover, the effects of imbalances in microbe–host interactions on homeostasis can lead to the progression of CVD. Alterations in the composition of gut flora and disruptions in gut microbial metabolism are implicated in the pathogenesis of CVD. Furthermore, the gut microbiota functions like an endocrine organ that produces bioactive metabolites, including trimethylamine/trimethylamine N‐oxide, short‐chain fatty acids and bile acids, which are also involved in host health and disease via numerous pathways. Thus, the gut microbiota and its metabolic pathways have attracted growing attention as a therapeutic target for CVD treatment. The fundamental purpose of this review was to summarize recent studies that have illustrated the complex interactions between the gut microbiota, their metabolites and the development of common CVD, as well as the effects of gut dysbiosis on CVD risk factors. Moreover, we systematically discuss the normal physiology of gut microbiota and potential therapeutic strategies targeting gut microbiota to prevent and treat CVD.

Letrozole and the Traditional Chinese Medicine, Shaofu Zhuyu Decoction, Reduce Endometriotic Disease Progression in Rats: A Potential Role for Gut Microbiota

“…ere are nearly 10 14 microbes in the human body, approximately 10 times the number of human cells, and the impact of the gut microbiota on human health and disease has attracted increasing scientific interest [25][26][27][28] in recent years, including in areas such as obesity, inflammatory diseases, cardiovascular diseases, and tumors. e gut microbiota is believed to be involved in the pathologic process of EMs [29].…”

Gut microbiome and osteoporosis

“…When the balance of the gut microbiota is disturbed due to certain factors, the body may suffer from diseases such as obesity, diabetes, or even cancers (such as colorectal cancer). 6 , 7 Accumulative research proposes that the gut microbiota is closely related to the regulation of bone metabolism, although its related mechanism has not been fully discovered. The rapid development of modern molecular biotechnology has facilitated the continuous discovery of the human microbiome, and may provide more information on early events about the pathogenesis of OP.…”

Long-Term Cardiovascular Diseases of Heatstroke: A Delayed Pathophysiology Outcome

“…As stated earlier, studies have shown that EHS disrupts the gastrointestinal barrier, leading to leakage of gut microbiota and its accompanying metabolites into the circulatory system [26]. Despite playing a proatherogenic role in IHD, elevated TMAO contributes to myocardial fibrosis, ventricular remodeling and dysfunction [39,40] . Further, TMAO levels are strongly associated with major adverse cardiovascular events in HF patients [41] .…”

“…Another possible mechanism of HF in HS patients is the role of gut microbiota-derived metabolite TMAO [ 26 , 39 - 41 ]. In the EHS animal study, TMAO had a biphasic response, rising early (0.5 hours post-EHS) before returning to baseline at three days post-EHS and subsequently rising later over the 14 days [ 19 ]⁠.…”